 LiveScience.com |
Omalizumab 'cuts seasonal asthma attacks in youth'
DailyIndia.com London, Mar 17: A clinical trial has found that the drug omalizumab, sold under the brand name Xolair, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among inner-city children and youth. … Drug may relieve kids' asthma in the fall Xolair Relieves Kids' Seasonal Asthma Attacks: Study Asthma Drug Cuts Seasonal Flares for Inner-City Kids |
View full post on asthma – Google News